[November 27, 2015] |
|
Research and Markets: Global Liver Cancer Pipeline Review 2015
Research and Markets (http://www.researchandmarkets.com/research/glcglc/liver_cancer)
has announced the addition of the "Liver
Cancer - Pipeline Review, 2015" report to their offering.
The report provides comprehensive information on the pipeline products
with comparative analysis of the products at various stages of
development. The report reviews major players involved in the pipeline
product development. It also provides information about clinical trials
in progress, which includes trial phase, trial status, trial start and
end dates, and, the number of trials for the key Liver Cancer diagnostic
tests pipeline products.
Scope
-
Extensive coverage of the Liver Cancer diagnostic tests under
development
-
The report reviews details of major pipeline products which includes,
product description, licensing and collaboration details and other
developmental activities
-
The report reviews the major players involed in the development of
Liver Cancer diagnostic tests and list all their pipeline projects
-
The coverage of pipeline products based on various stages of
development ranging from Early Development to Approved / Issued stage
-
The report provides key clinical trial data of ongoing trials specific
to pipeline products
-
Recent developments in the segment / industry
Key Topics Covered:
1 Tables & Figures
2 Introduction
3 Products under Development
4 Liver Cancer - Pipeline Products under Development by Companies
5 Liver Cancer Companies and Product Overview
6 Liver Cancer- Recent Developments
7 Appendix
Companies Mentioned
-
Abbott Diagnostics
-
Almac Diagnostics Limited
-
AXO Science S.A.S.
-
BioMark Technologies Inc.
-
China Sky One Medical, Inc.
-
Digna Biotech, S.L.
-
Drexel University
-
German Cancer Research Center
-
Glycotest, Inc.
-
Imperial College London
-
IntegraGen SA
-
Matrix-Bio, Inc.
-
NanoString Technologies, Inc.
-
National Cancer Institute
-
Orion Genomics LLC
-
PleX Diagnostics
-
ProMIS Neurosciences Inc.
-
Proplex Technologies, Llc
-
Proteome Sciences Plc
-
Roche Diagnostics International Ltd.
-
TrovaGene, Inc.
-
University of Chicago
-
University of Rochester
-
Viomics Inc.
-
XEPTAGEN SpA
-
Xiamen Zeesan Biotech Co.,Ltd
For more information visit http://www.researchandmarkets.com/research/glcglc/liver_cancer
View source version on businesswire.com: http://www.businesswire.com/news/home/20151127005252/en/
[ Back To TMCnet.com's Homepage ]
|